1. Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia. (14th June 2022) Authors: Mulligan, Stephen P.; Opat, Stephen; Marlton, Paula; Kuss, Bryone; Gerungan, Poppy; Puig, Andrea; McGeachie, Marija; Tam, Constantine S. Journal: British journal of haematology Issue: Volume 198:Number 4(2022) Page Start: 790 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗